Brief: Xvivo Perfusion Gets Patent Approval In Europe
Aug 21 (Reuters) - Xvivo Perfusion AB XVIVO.ST :
* GETS PATENT APPROVAL IN EUROPE
* HAS RECEIVED EUROPEAN PATENT APPROVAL FOR PERFADEX PLUS
FOR COLD
PRESERVATION OF LUNGS
* WORK ON REGULATORY APPROVAL FOR PERFADEX® PLUS IS ONGOING,
WITH
THE AIM THAT THE PRODUCT IS APPROVED IN ALL MARKETS IN 2019
Source text for Eikon: ID:nWkr6KB8JG
Further company coverage: XVIVO.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Xvivo Perfusion AB
See all newsSweden's XVIVO Q3 revenue beat expectations on thoracic sales
Brief: Xvivo Q3 EBIT SEK 28 Million
Brief: Xvivo Receives CE Certificates For Heart Preservation Technology
Brief: XVIVO Gets FDA Approval For Additional Patient Enrollment
Sweden's XVIVO Q2 sales beat estimates, helped by thoracic segment strength